T1	PROC 46 66	Estudio de extensión
T2	PROC 86 106	evaluar la seguridad
#1	AnnotatorNotes T2	C1705187; Safety Study; Research Activity
T3	CHEM 110 117	ELND005
#2	AnnotatorNotes T3	C4053647; ELND005; Organic Chemical · Pharmacologic Substance
T4	PROC 131 142	tratamiento
#3	AnnotatorNotes T4	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T5	DISO 149 158	agitación
#4	AnnotatorNotes T5	C0085631; Agitation; Sign or Symptom
T6	DISO 193 216	enfermedad de Alzheimer
#5	AnnotatorNotes T6	C0002395; Alzheimer's Disease; Disease or Syndrome
T7	DISO 257 266	Agitación
#6	AnnotatorNotes T7	C0085631; Agitation; Sign or Symptom
T8	DISO 298 321	enfermedad de Alzheimer
#7	AnnotatorNotes T8	C0002395; Alzheimer's Disease; Disease or Syndrome
T9	DISO 349 358	Agitación
#8	AnnotatorNotes T9	C0085631; Agitation; Sign or Symptom
T10	DISO 390 413	enfermedad de Alzheimer
#9	AnnotatorNotes T10	C0002395; Alzheimer's Disease; Disease or Syndrome
T11	PROC 462 498	Consentimiento informado por escrito
#10	AnnotatorNotes T11	C0811741; Obtain informed written consent; Health Care Activity
T12	CHEM 657 664	fármaco
#11	AnnotatorNotes T12	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T13	CHEM 834 841	fármaco
#12	AnnotatorNotes T13	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T14	DISO 938 956	trastornos médicos
T15	DISO 959 967	demencia
#13	AnnotatorNotes T15	C0497327; Dementia; Mental or Behavioral Dysfunction
T16	PROC 1007 1043	estudio de extensión de la seguridad
T17	DISO 164 175	agresividad
#14	AnnotatorNotes T17	C0557883; Feeling aggressive; Finding
T18	DISO 269 280	agresividad
#15	AnnotatorNotes T18	C0557883; Feeling aggressive; Finding
T19	DISO 361 372	agresividad
#16	AnnotatorNotes T19	C0557883; Feeling aggressive; Finding
T20	Date 13 17	2012
T21	Duration 70 80	36 semanas
T22	Route 118 122	oral
#17	AnnotatorNotes T22	C1527415; Oral Route of Drug administration; Functional Concept
T23	LIVB 179 188	pacientes
#18	AnnotatorNotes T23	C0030705; Patients; Patient or Disabled Group
T24	LIVB 284 293	pacientes
#19	AnnotatorNotes T24	C0030705; Patients; Patient or Disabled Group
T25	LIVB 376 385	pacientes
#20	AnnotatorNotes T25	C0030705; Patients; Patient or Disabled Group
T26	Date 590 602	la semana 12
T28	Date 807 818	actualmente
T29	DEVI 844 887	dispositivo experimental o en investigación
#21	AnnotatorNotes T29	C0237568; Experimental device; Research Device | C2346570; Investigational Medical Device; Medical Device
T27	PROC 580 586	visita
#22	AnnotatorNotes T27	C1512346; Patient Visit; Health Care Activity
#23	AnnotatorNotes T14	C0012634; Disease; Disease or Syndrome
#24	AnnotatorNotes T28	C0521116; Current (present time); Temporal Concept 
T30	Neg_cue 680 682	No
T31	CONC 689 707	contraindicaciones
A1	Assertion T31 Negated
#25	AnnotatorNotes T31	C0522473; Contraindication; Qualitative Concept
T32	Neg_cue 979 986	impedir
T33	Observation 991 1043	finalizara este estudio de extensión de la seguridad
A2	Assertion T33 Negated
T34	Observation 903 916	empeoramiento
#26	AnnotatorNotes T34	C1457868; Worse; Finding
R1	Negation Arg1:T32 Arg2:T33	
R2	Has_Duration_or_Interval Arg1:T1 Arg2:T21	
R3	Used_for Arg1:T3 Arg2:T4	
R4	Has_Route_or_Mode Arg1:T3 Arg2:T22	
R5	Experiences Arg1:T23 Arg2:T3	
R6	Experiences Arg1:T23 Arg2:T5	
R7	Experiences Arg1:T23 Arg2:T17	
R8	Experiences Arg1:T23 Arg2:T6	
R9	Experiences Arg1:T24 Arg2:T7	
R10	Experiences Arg1:T24 Arg2:T18	
R11	Overlap Arg1:T5 Arg2:T6	
R12	Overlap Arg1:T17 Arg2:T6	
T35	Quantifier_or_Qualifier 217 233	moderada o grave
#27	AnnotatorNotes T35	C1299393; Moderate to severe; Qualitative Concept
R13	Has_Quantifier_or_Qualifier Arg1:T6 Arg2:T35	
R14	Experiences Arg1:T24 Arg2:T8	
R15	Experiences Arg1:T25 Arg2:T10	
R16	Experiences Arg1:T25 Arg2:T9	
R17	Experiences Arg1:T25 Arg2:T19	
T36	Quantifier_or_Qualifier 417 433	moderada a grave
#28	AnnotatorNotes T36	C1299393; Moderate to severe; Qualitative Concept
R18	Has_Quantifier_or_Qualifier Arg1:T10 Arg2:T36	
R19	Overlap Arg1:T27 Arg2:T26	
R20	Overlap Arg1:T27 Arg2:T12	
R21	Negation Arg1:T30 Arg2:T31	
T37	Observation 735 761	participando en el estudio
#29	AnnotatorNotes T37	C1278516; Patient participation status; Finding
R22	Overlap Arg1:T13 Arg2:T28	
R23	Overlap Arg1:T29 Arg2:T28	
T38	Quantifier_or_Qualifier 917 930	significativo
#30	AnnotatorNotes T38	C1546944; Event Seriousness - Significant; Qualitative Concept
R24	Has_Quantifier_or_Qualifier Arg1:T34 Arg2:T38	
R25	Before Arg1:T14 Arg2:T34	
R26	Before Arg1:T15 Arg2:T34	
R27	Before Arg1:T34 Arg2:T33	
#31	AnnotatorNotes T33	C2732579; Completion of clinical trial; Finding (?)
A3	Experiencer T23 Patient
A4	Experiencer T24 Patient
A5	Experiencer T25 Patient
